The precision medicine and multi-omics forum at BIO Asia-Taiwan 2026 brought together genomic scientists, microbiome researchers, and clinical methodologists to explore liquid biopsy diagnostics, gut microbiota profiling, and personalized trial design. Pan-Chyr Yang, President of Institute for Biotechnology and Medicine Industry (IBMI), opened a session on “AI x Multi-Omics in Cancer and Chronic Disease”. He … Beyond Population Averages: The Dawn of Dynamic, N=1 Precision Medicine Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.